Results 11 to 20 of about 27,136 (186)

Pneumococcal Vaccines

open access: yesMicrobiology Spectrum, 2019
Streptococcus pneumoniae is a Gram-Positive pathogen that is a major causative agent of pneumonia, otitis media, sepsis and meningitis across the world.
D. E. Briles   +4 more
doaj   +4 more sources

Pneumococcal vaccines in China. [PDF]

open access: yesHum Vaccin Immunother
Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention.
Wang S   +6 more
europepmc   +4 more sources

Pneumococcal vaccine [PDF]

open access: yesPostgraduate Medical Journal, 1997
Summary Streptococcus pneumoniae is a frequent cause of pneumonia and meningitis. This article looks at the pneumococcal vaccine, its uses, efficacy, and adverse effects and how vaccination may be improved. We also look at the role of the new conjugate vaccines.
K L, Hattotuwa, C R, Hind
openaire   +2 more sources

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Although routine vaccinations in children decreased during the coronavirus disease 2019 (COVID-19) pandemic, pneumococcal vaccine coverage in older adults has remained unknown.
Akira Komori   +2 more
doaj   +1 more source

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned

open access: yesBMC Public Health, 2019
Background Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden.
S. F. La Vincente   +18 more
doaj   +1 more source

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

open access: yesVaccines, 2022
Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries.
Tianjing Hu   +11 more
doaj   +1 more source

Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

open access: yesVaccines, 2020
Various studies indicate that vaccination, especially with pneumococcal vaccines, protects against symptomatic cases of SARS-CoV-2 infection and death.
Robert Root-Bernstein
doaj   +1 more source

[Pneumococcal vaccine].

open access: yesAnnali di igiene : medicina preventiva e di comunita, 2001
Gli autori descrivono le caratteristiche del vaccino anti-pneumococcico polisaccaridi, ponendo una particolare attenzione alla sua efficacia e tollerabilità€ nella popolazione anziana.
D'ALESSANDRO, Daniela, Y. Kodra
openaire   +6 more sources

Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]

open access: yesJournal of Infection and Chemotherapy, 2013
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Joon Young, Song   +3 more
openaire   +2 more sources

Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?

open access: yesmBio, 2016
Streptococcus pneumoniae remains an important human pathogen. For more than 100 years, there have been vaccine efforts to prevent pneumococcal infection. The pneumococcal conjugate vaccines have significantly reduced invasive disease.
Larry S. McDaniel, Edwin Swiatlo
doaj   +1 more source

Home - About - Disclaimer - Privacy